Result of Court Hearing


 

TIDMCUR TIDMAVCT 
 
RNS Number : 1248O 
Curidium Medica PLC 
02 March 2009 
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR 
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE 
RELEVANT LAWS OF SUCH JURISDICTION 
 
 
London, 2 March, 2009 
Curidium Medica plc ("Curidium") 
and 
Avacta Group plc ("Avacta") 
 
 
 
 
RESULT OF COURT HEARING 
 
 
The boards of Curidium Medica plc (the "Company") and Avacta Group plc are 
pleased to announce that the High Court of Justice has today made an order 
sanctioning the scheme of arrangement to effect the recommended all share 
acquisition of the Company approved by the shareholders of the Company on 11 
February 2009. Also today, the High Court of Justice has made an order 
confirming the associated Reduction of Capital and the Cancellation of the 
deferred shares in the capital of the Company. 
 
 
The Effective Date of the Scheme is expected to be 3 March 2009, with the 
cancellation of admission of the Company's ordinary shares to trading on AIM 
expected to be at 8 am on 4 March 2009. The commencement of trading of AIM of 
the New Avacta Shares issued under the terms of the Scheme is expected to be at 
8 am on 5 March 2009. 
 
 
Pending the Effective Date of the Scheme, trading in the Company's shares on AIM 
is expected to be suspended after the close of business today. 
 
 
Definitive certificates for the New Avacta Shares are expected to be dispatched 
by 17 March 2009. It is expected that the New Avacta Shares will be credited to 
CREST accounts on 5 March 2009. 
 
 
Capitalised terms used in this announcement have the same meanings as in the 
Scheme Document. 
 
 
Enquiries 
 
 
Curidium 
Dr. Barry Porter, Chairman 
Rob Smith, Chief Financial Officer 
Tel: 020 7554 5100 
 
 
Avacta 
Dr Alastair Smith, Chief Executive Officer 
Tim Sykes, Chief Financial Officer 
Tel: 0870 835 4367 
 
 
FinnCap (financial adviser to Curidium) 
Charlie Cunningham 
Tel: 020 7600 1658 
 
 
Novum Securities Limited (financial adviser to Avacta) 
Henry Turcan 
Tel: 020 7562 4700 
 
 
 
 
Haggie Financial (PR to Avacta) 
Nicholas Nelson 
Tel: 020 7417 8989 
 
 
 
 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 STRCKBKPDBKDANK

Curidium Medica (LSE:CUR)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024